Sleep Apnoea Adverse Effects on Cancer: True, False, or Too Many Confounders?

Abstract

Obstructive sleep apnoea (OSA) is a prevalent disorder associated with increased cardiovascular, metabolic and neurocognitive morbidity. Recently, an increasing number of basic, clinical and epidemiological reports have suggested that OSA may also increase the risk of cancer, and adversely impact cancer progression and outcomes. This hypothesis is convincingly supported by biological evidence linking certain solid tumours and hypoxia, as well as by experimental studies involving cell and animal models testing the effects of intermittent hypoxia and sleep fragmentation that characterize OSA. However, the clinical and epidemiological studies do not conclusively confirm that OSA adversely affects cancer, even if they hold true for specific cancers such as melanoma. It is likely that the inconclusive studies reflect that they were not specifically designed to test the hypothesis or because of the heterogeneity of the relationship of OSA with different cancer types or even sub-types. This review critically focusses on the extant basic, clinical, and epidemiological evidence while formulating proposed directions on how the field may move forward.

• Authors: David Gozal, Isaac Almendros, Amanda I Phipps, Francisco Campos-Rodriguez, Miguel A Martínez-García, Ramon Farré
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 21 Issue 22 (Nov 20 2020) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 33233617 (Publication Type: Journal Article, Review)

Topics

• Aging (genetics, metabolism, pathology)
• Animals
• Cohort Studies
• Cross-Sectional Studies
• Disease Models, Animal
• Disease Progression
• Humans
• Hypoxia (genetics, metabolism, pathology)
• Mice
• Neoplasms (genetics, metabolism, pathology)
• Obesity (genetics, metabolism, pathology)
• Risk Factors
• Sleep Apnea, Obstructive (genetics, metabolism, pathology)
• Sleep Deprivation (genetics, metabolism, pathology)